ALLENA PHARMACEUTICALS INC (ALNA) Stock Income Statement
NASDAQ:ALNA - Nasdaq - US0181191075 - Common Stock - Currency: USD
| TTM (2022-6-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 41.03M | 47.65M | 31.99M | 46.92M | 35.59M | |||
| Research and Development | 28.77M | 34.97M | 20.38M | 37.24M | 26.38M | |||
| Selling, General, and Administrative Expenses | 12.26M | 12.68M | 11.60M | 9.68M | 9.22M | |||
| Operating Income | -41.03M | -47.65M | -31.99M | -46.92M | -35.59M | |||
| Interest Income/Expense | -855.00K | -976.00K | -510.00K | 270.00K | 580.00K | |||
| Other Income/Expense | -1.42M | -38.00K | -350.00K | -80.00K | -10.00K | |||
| Non Recurring Items | N/A | 0.00 | 0.00 | -610.00K | -620.00K | |||
| Income Before Taxes | -43.30M | -48.66M | -32.85M | -47.34M | -35.65M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -43.30M | -48.66M | -32.85M | -47.34M | -35.65M | |||
| EBITDA | -40.57M | -47.29M | -31.82M | -46.76M | -35.51M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.51 | -0.72 | -1.01 | -2.13 | -1.72 | |||
| Non GAAP EPS | -0.49 | -0.73 | -1.03 | -2.13 | -1.72 | |||
| Statistics | ||||||||
All data in USD